Damien Basille

Dr. Damien Basille

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2016 in Lung
Verified
Journal Article
Closed access
PDF file
DBDamien Basille
Damien Basille
NPNathalie Plouvier
Nathalie Plouvier
CTCharlotte Trouve
Charlotte Trouve
PDPierre Duhaut
Pierre Duhaut
CAClaire Andrejak
Claire Andrejak
VJVincent Jounieaux
Vincent Jounieaux

1 March 2020 in Clinical Lung Cancer
Verified
Journal Article
Closed access
OLOlivier Leleu
Olivier Leleu
DBDamien Basille
Damien Basille
MAMarianne Auquier
Marianne Auquier
CCCaroline Clarot
Caroline Clarot
EHEstelle Hoguet
Estelle Hoguet
VJVincent Jounieaux
Vincent Jounieaux

20 January 2023 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
FSFrederic Schlemmer
Frederic Schlemmer
SVSimon Valentin
Simon Valentin
LBLaurent Boyer
Laurent Boyer
AGAnne Guillaumot
Anne Guillaumot
FCFrançois Chabot
François Chabot
BMBernard Maitre
Bernard Maitre
Background: Survivors of severe-to-critical coronavirus disease 2019 (COVID-19) may have functional impairment, radiological sequelae and persistent symptoms requiring prolonged follow-up. This pragmatic study aimed to describe their clinical follow-up and determine their respiratory recovery trajectories, and the factors that could influence them and their health-related quality of life.Methods: Adults hospitalised for severe-to-critical COVID-19 were evaluated at 3 months and up to 12 months post-hospital discharge in this prospective, multicentre, cohort study.Results: Among 485 enrolled participants, 293 (60%) were reassessed at 6 months and 163 (35%) at 12 months; 89 (51%) and 47 (27%) of the 173 participants initially managed with standard oxygen were reassessed at 6 and 12 months, respectively. At 3 months, 34%, 70% and 56% of the participants had a restrictive lung defect, impaired diffusing capacity of the lung for carbon monoxide (DLCO) and significant radiological sequelae, respectively. During extended follow-up, bothDLCOand forced vital capacity percentage predicted increased by means of +4 points at 6 months and +6 points at 12 months. Sex, body mass index, chronic respiratory disease, immunosuppression, pneumonia extent or corticosteroid use during acute COVID-19 and prolonged invasive mechanical ventilation (IMV) were associated withDLCOat 3 months, but not its trajectory thereafter. Among 475 (98%) patients with at least one chest computed tomography scan during follow-up, 196 (41%) had significant sequelae on their last images.Conclusions: Although pulmonary function and radiological abnormalities improved up to 1 year post-acute COVID-19, high percentages of severe-to-critical disease survivors, including a notable proportion of those managed with standard oxygen, had significant lung sequelae and residual symptoms justifying prolonged follow-up.

1 July 2018 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
DBDamien Basille
Damien Basille
RTReimar Wernich Thomsen
Reimar Wernich Thomsen
MMMorten Madsen
Morten Madsen
PDPierre Duhaut
Pierre Duhaut
CAClaire Andrejak
Claire Andrejak
Henrik Toft SørensenHenrik Toft Sørensen
Henrik Toft Sørensen

26 July 2019 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
MTMarine Timmerman
Marine Timmerman
DBDamien Basille
Damien Basille
ABAurélie Basille-Fantinato
Aurélie Basille-Fantinato
MBMickaël E. Baud
Mickaël E. Baud
LRLionel Rebibo
Lionel Rebibo
JLJean-Daniel Lalau
Jean-Daniel Lalau

1 January 2022 in Clinical Lung Cancer
Verified
Journal Article
Closed access
OLOlivier Leleu
Olivier Leleu
DBDamien Basille
Damien Basille
MAMarianne Auquier
Marianne Auquier
CCCaroline Clarot
Caroline Clarot
EHEstelle Hoguet
Estelle Hoguet
VJVincent Jounieaux
Vincent Jounieaux